<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/01E53956-BF13-4C46-88E2-94DD05716E14"><gtr:id>01E53956-BF13-4C46-88E2-94DD05716E14</gtr:id><gtr:name>Centre for Cooperative Research in Biomaterials (CIC BiomaGUNE)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E4599F86-E5D9-40AD-A427-4782E12EA8BF"><gtr:id>E4599F86-E5D9-40AD-A427-4782E12EA8BF</gtr:id><gtr:name>Swiss Federal Institute of Technology in Lausanne (EPFL)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB"><gtr:id>AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB</gtr:id><gtr:name>Oxford University Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Churchill Site</gtr:line1><gtr:line2>Old Road</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 7LJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6F2B788C-BBD1-49B8-A376-73334F7D7F7E"><gtr:id>6F2B788C-BBD1-49B8-A376-73334F7D7F7E</gtr:id><gtr:name>Regeneron Pharmaceuticals, Inc.</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/314A3F92-9F78-4782-891F-990F9E739DC4"><gtr:id>314A3F92-9F78-4782-891F-990F9E739DC4</gtr:id><gtr:name>Medical University of Vienna</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E3BB202F-E9D1-4FB6-B29C-A98ED2C9AECF"><gtr:id>E3BB202F-E9D1-4FB6-B29C-A98ED2C9AECF</gtr:id><gtr:name>University of Seville</gtr:name><gtr:address><gtr:line1>Avda</gtr:line1><gtr:line2>Reina Mercedes, S/n</gtr:line2><gtr:line4>E-41012 Seville</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/01E53956-BF13-4C46-88E2-94DD05716E14"><gtr:id>01E53956-BF13-4C46-88E2-94DD05716E14</gtr:id><gtr:name>Centre for Cooperative Research in Biomaterials (CIC BiomaGUNE)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E4599F86-E5D9-40AD-A427-4782E12EA8BF"><gtr:id>E4599F86-E5D9-40AD-A427-4782E12EA8BF</gtr:id><gtr:name>Swiss Federal Institute of Technology in Lausanne (EPFL)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB"><gtr:id>AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB</gtr:id><gtr:name>Oxford University Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Churchill Site</gtr:line1><gtr:line2>Old Road</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 7LJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6F2B788C-BBD1-49B8-A376-73334F7D7F7E"><gtr:id>6F2B788C-BBD1-49B8-A376-73334F7D7F7E</gtr:id><gtr:name>Regeneron Pharmaceuticals, Inc.</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/314A3F92-9F78-4782-891F-990F9E739DC4"><gtr:id>314A3F92-9F78-4782-891F-990F9E739DC4</gtr:id><gtr:name>Medical University of Vienna</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E3BB202F-E9D1-4FB6-B29C-A98ED2C9AECF"><gtr:id>E3BB202F-E9D1-4FB6-B29C-A98ED2C9AECF</gtr:id><gtr:name>University of Seville</gtr:name><gtr:address><gtr:line1>Avda</gtr:line1><gtr:line2>Reina Mercedes, S/n</gtr:line2><gtr:line4>E-41012 Seville</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/272F8C15-329A-4E57-8F25-7EA3E44849A9"><gtr:id>272F8C15-329A-4E57-8F25-7EA3E44849A9</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Jackson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UU_12010%2F2"><gtr:id>613C76AB-24C7-4395-9D2D-4CB8A28172D9</gtr:id><gtr:title>The biology of lymphatics in inflammation, immunity and cancer</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UU_12010/2</gtr:grantReference><gtr:abstractText>We are investigating how cells enter and move within lymphatic vessels so that in the future we can develop new therapies to block inflammation, prevent tumour spread, and make the delivery of vaccines to emerging infections more efficient. The lymphatic vessels form a dense network that intertwines the blood circulation and whose main functions are to maintain fluid balance and to transport cells carrying foreign antigen to the lymph nodes where they meet T and B cells and stimulate the immune response. Importantly, the lymphatics also contribute to diseases such as cancer by allowing metastatic tumours (e.g. skin and breast cancer) to spread to other parts of the body, and they act as a reservoir for malignant cells. Even though the involvement of lymphatics in disease have been known for a long time, their biology is still not well understood and so research in my group is dedicated to understanding how immune cells and tumours enter and navigate within the lymphatics. Thus far we have discovered that in inflammation, entry of immune cells carrying proteins from infectious agents depends critically on recognition of inflammation-induced protein receptors on the surface of lymphatic vessels, and that this is obligatory for the generation of the immune response to infection. We have also identified a separate mechanism that controls tumour cell entry to the lymphatics during lymph node metastasis in murine tumours and humans. 
We are also particularly interested in researching a molecule in lymphatics called LYVE-1 and we anticipate that further research in this area will reveal new ways to block inflammation, and to promote protective immunity to emerging infectious agents by enhancing vaccine delivery.</gtr:abstractText><gtr:technicalSummary>Goals To investigate mechanisms of lymphatic trafficking in inflammation, immunity and cancer. In addition to maintaining fluid balance and tissue homeostasis the lymphatics also provide a conduit for trafficking of antigen presenting cells to lymph nodes for activation of nave T cells, and in so doing they allow a route for tumour metastasis. Recent work has focused on understanding the key molecular mechanisms regulating entry of leukocytes and tumour cells to lymphatics and their subsequent trafficking to lymph nodes. We have discovered a separate new integrin and chemokine dependent pathway for translymphatic migration of dendritic cells (DC) that functions in inflammation (1) and demonstrated its importance for dermal antigen delivery during T cell responses - identifying a new potential target for intervention (2). We have focused on two lectin-like receptors of the Link superfamily, LYVE-1 and CD44. LYVE-1 is the major HA receptor of lymphatic endothelial cells and was originally cloned and characterized in my laboratory (3). We have shown that in addition to mediation of lymphatic trafficking of DC, LYVE-1 also plays a role in lymphatic invasion in tumour metastasis and in the resolution of inflammation in a model of acute lung injury. We have identified tumour lymphatic endotherlial cell markers (TLEM) and have shown these to be important in nodal metastasis in a range of murine and human cancers (4). The crystal structure and activation mechanism of CD44, an inflammatory leukocyte HA receptor closely related to LYVE-1 and which plays a pivotal role in transmigration of activated leukocytes across inflamed vascular endothelium have been determined (5). Future research plans Future work will concentrate on the definition of the lymphatic entry points and molecular mechanisms for transmigration of different leukocyte populations. The use of microscopic imaging and structure/function analyses will allow us to determine how receptors such as LYVE-1 mediate cell trafficking in animal models of inflammation. Moreover, we will pursue the 3D structure of the LYVE-1 ectodomain and elucidate the mechanisms regulating it's interaction with hyaluronan, search for additional LYVE-1 ligands mediating leukocyte trafficking, define downstream signalling pathways mediating transendothelial migration and investigate function blocking antibodies of potential therapeutic value for inflammation and cancer. References: (1) Johnson et al. 2006 J Exp Med 203: 2763; (2) Teoh et al. 2009 J Immunol 182: 2425; (3) Gale et al 2007 Mol Cell Biol 27: 595; (4) Clasper et al. 2008 Cancer Res 68:7293; (5) Banerji et al. 2007 Nature Struct Mol Biol 14:234</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>3252000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, San Francisco</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Anatomy</gtr:department><gtr:description>High Resolution confocal Lung Imaging</gtr:description><gtr:id>E0B89EC6-72BB-4A48-9DB7-E7488E5C226D</gtr:id><gtr:impact>Obtained critical data for inclusion in a manuscript under preparation for submission to scientific journal</gtr:impact><gtr:outcomeId>CV8nNG1aY1q-1</gtr:outcomeId><gtr:partnerContribution>Carried out perfusion fixation and inflation of lungs and prepared sections for confocal imaging and z sectioning to identify critical cell population in alveolae</gtr:partnerContribution><gtr:piContribution>Provided reagents and intellectual input</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wellcome Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Wellcome Trust Centre for Cell-Matrix Research</gtr:department><gtr:description>Tony Day collaboration</gtr:description><gtr:id>9890F93D-2912-420A-867B-D5FCA44D5DED</gtr:id><gtr:impact>Ongoing intellectual exchange. Generation of key publications 
27733683 26823460 and impending new publication describing crystal structure of ligand binding domain of lymphatic hyaluronan receptor LYVE-1</gtr:impact><gtr:outcomeId>cnNPqJm8cVo-1</gtr:outcomeId><gtr:partnerContribution>Expertise in Physical techniques including NMR spectroscopy calorimetry, small angle X ray scattering. Production and purification of hyaluronan oligosaccharides and analogues for binding studies and co-crystallisation with receptors.</gtr:partnerContribution><gtr:piContribution>Protein expression and purification, Protein structural analysis, intellectual input, co-authoring</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Sir William Dunn School of Pathology</gtr:department><gtr:description>Errin Johnson collaboration</gtr:description><gtr:id>E68E5D29-410B-4307-8DB9-267D44641943</gtr:id><gtr:impact>Ongoing</gtr:impact><gtr:outcomeId>56d9f696cb92e4.66954090-1</gtr:outcomeId><gtr:partnerContribution>Electron microscopy</gtr:partnerContribution><gtr:piContribution>Advice and intellectual contribution</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical University of Vienna</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:department>Clinical Institute of Pathology</gtr:department><gtr:description>Lung lymphatics mAbs</gtr:description><gtr:id>5C2FF8D5-E5A0-40BE-A6AA-35F9594F44F8</gtr:id><gtr:impact>Manuscript in preparation</gtr:impact><gtr:outcomeId>odRMoy6WnDr-1</gtr:outcomeId><gtr:partnerContribution>EM and confocal imaging of lung vasculature</gtr:partnerContribution><gtr:piContribution>Generation of mAbs for imaging vasculature in lung sections</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Regeneron Pharmaceuticals, Inc.</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Regeneron collaboration</gtr:description><gtr:id>3A497D89-8F33-4701-BBC1-483F47A472F8</gtr:id><gtr:impact>Generated publication (Johnson et al Nature Immunology In Press 2017 ) Stimulating ongoing research in new areas, identification of possible new targets for anti-inflammatory therapy and future access to further transgenic animals</gtr:impact><gtr:outcomeId>dZodyofXEHK-1</gtr:outcomeId><gtr:partnerContribution>Generated transgenic mice, providing intellectual contributions and technical expertise for mAb production and testing</gtr:partnerContribution><gtr:piContribution>Characterisation of phenotype of LYVE1 KO mice, generation of potential human function blocking mAbs and authoring of publication</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Medicine</gtr:department><gtr:description>Aspp1 collaboration</gtr:description><gtr:id>87638977-CB09-491F-8821-D262C2B05ECA</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:outcomeId>56d9ef42282662.11766743-1</gtr:outcomeId><gtr:partnerContribution>Expertise reagents and advice</gtr:partnerContribution><gtr:piContribution>Expertise reagents and advice</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Sir William Dunn School of Pathology</gtr:department><gtr:description>David Greaves collaboration</gtr:description><gtr:id>748904A3-0313-485F-923A-9B1F3AD89658</gtr:id><gtr:impact>Manuscript in Blood; describing utility of CD68 transgenic reporter mice for macrophage trafficking studies

Manuscript in preparation for J Biol Chem</gtr:impact><gtr:outcomeId>TijfaW5VJgu-1</gtr:outcomeId><gtr:partnerContribution>Advice and expertise in measurement of endothelial cell junctional permeability
Contribution of transgenic reporter mice</gtr:partnerContribution><gtr:piContribution>Intellectual input and experimental design
Animal experiments involving cell trafficking</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Human Immunology Unit</gtr:department><gtr:description>Super resolution microscopy</gtr:description><gtr:id>78A38EA4-0A68-44A6-A624-ECD1271AC81D</gtr:id><gtr:impact>Multidisciplinary collaboration
Manuscript submitted to Scientific Reports 2016</gtr:impact><gtr:outcomeId>54610186226fb4.64420725-1</gtr:outcomeId><gtr:partnerContribution>Performing STED microscopy and analysis of data</gtr:partnerContribution><gtr:piContribution>Preparation of primary cells and transfectants, and appropriate mAbs and conjugates for STED microscopic evaluation of receptor surface distribution</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford University Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>David Coleman collaboration</gtr:description><gtr:id>5470190C-93E7-4A42-9776-8118E72687D7</gtr:id><gtr:impact>Regular supply of primary cells vital for our research and fundamental to most publications coming from my group</gtr:impact><gtr:outcomeId>r1ibSxMpRHf-1</gtr:outcomeId><gtr:partnerContribution>Provision of human skin samples for isolation of primary cells</gtr:partnerContribution><gtr:piContribution>Regular immunoisolation of primary endothelial cells from human surgically excised tissue - generation of materials essential for our research</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Medicine</gtr:department><gtr:description>Luxheng Xue collaboration</gtr:description><gtr:id>B371BD2A-E024-4CD2-906E-EBA7A6C81941</gtr:id><gtr:impact>Manuscript in J allergy and Clinical Immunol PMID 25441644</gtr:impact><gtr:outcomeId>5461055a756bb7.41898604-1</gtr:outcomeId><gtr:partnerContribution>Performance of experiments to investigate neutrophil : T cell crosstalk</gtr:partnerContribution><gtr:piContribution>Advice and experimental design. Discussion of data and manuscript editing</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical University of Vienna</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:department>Clinical Institute of Pathology</gtr:department><gtr:description>Fluorescence and EM imaging of lung</gtr:description><gtr:id>92374478-DAC7-4F57-8F9C-0AFA2D06A886</gtr:id><gtr:impact>Obtained important data for inclusion in manuscript under preparation for publication in scientific journal</gtr:impact><gtr:outcomeId>eAEkX4Sqdfz-1</gtr:outcomeId><gtr:partnerContribution>Performed immunoelectron microscopy and immunofluorescence imaging of thin sections of mouse alveolae</gtr:partnerContribution><gtr:piContribution>Provision of reagents and intellectual input</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Swiss Federal Institute of Technology in Lausanne (EPFL)</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:department>Institute of Bioengineering</gtr:department><gtr:description>Melody Swartz collaboration</gtr:description><gtr:id>4982B171-5B93-469C-83B8-A22FDA1290B7</gtr:id><gtr:impact>Transfer of specialist expertise</gtr:impact><gtr:outcomeId>SyW8EA6yY1w-1</gtr:outcomeId><gtr:partnerContribution>Training in the immunoisolation of lymphatic endothelial cells from mice using podoplanin mAbs. Training in intravital imaging of lymphatics.</gtr:partnerContribution><gtr:piContribution>Travel to partners laboratory for training</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Sir William Dunn School of Pathology</gtr:department><gtr:description>Kevi Maloy collaboration</gtr:description><gtr:id>D716AF4A-B25E-4293-96B9-3F0484F50297</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:outcomeId>56d9f0534ee8d8.56998015-1</gtr:outcomeId><gtr:partnerContribution>Reagents expertise and advice</gtr:partnerContribution><gtr:piContribution>Reagents expertise and advice</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Seville</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:department>Department of Bioorganic Chemistry</gtr:department><gtr:description>Jesus Angulo NMR collaboration</gtr:description><gtr:id>068B4BBB-5986-41ED-A0E7-2199149445AD</gtr:id><gtr:impact>In progress</gtr:impact><gtr:outcomeId>Qf6vTwf4Doq-1</gtr:outcomeId><gtr:partnerContribution>Performed STD NMR analyses</gtr:partnerContribution><gtr:piContribution>Provision of recombinant soluble CD44 protein for STD NMR experiments</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Medical and Dental Sciences</gtr:department><gtr:description>Steven Watson collaboration</gtr:description><gtr:id>42A2D794-A12A-402C-B50B-6E7F483E7728</gtr:id><gtr:impact>Publication in J Biol Chem PMID 25368330</gtr:impact><gtr:outcomeId>56d9f603c8e530.65182244-1</gtr:outcomeId><gtr:partnerContribution>Expertise advice and reagents</gtr:partnerContribution><gtr:piContribution>Expertise advice and reagents</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Sir William Dunn School of Pathology</gtr:department><gtr:description>Surface Plasmon resonance (Biacore) analysis of receptor ligand binding affinity</gtr:description><gtr:id>C9DA68B8-C57E-43FA-A02F-12FCAE55B0C7</gtr:id><gtr:impact>Manuscript that is about to be submitted to J Biol Chem</gtr:impact><gtr:outcomeId>5460ffca8f8ec4.14636731-1</gtr:outcomeId><gtr:partnerContribution>Mathematical evaluation of binding data from kinetic analyses and derivation of accurate Kd values</gtr:partnerContribution><gtr:piContribution>Generated recombinant soluble hyaluronan receptors and mutants thereof and performed Biacore analyses using hyaluronan coated chip to determine binding affinities</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Infection and Immunity</gtr:department><gtr:description>Awen Gallimore collaboration</gtr:description><gtr:id>76E15C48-B8FC-4B7E-9F13-99CD42EDFD15</gtr:id><gtr:impact>Manuscript in International Journal of Cancer PMID 24142504</gtr:impact><gtr:outcomeId>546103abaf7688.68084246-1</gtr:outcomeId><gtr:partnerContribution>Carried out studies into mouse fibrosarcoma tumour development and role of different vasculatures in T cell recruitment to tumour</gtr:partnerContribution><gtr:piContribution>Advice on experimental design and evaluation of experimental data from mouse tumour model</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Wellcome Trust Centre for Human Genetics</gtr:department><gtr:description>Robert Gilbert collaboration</gtr:description><gtr:id>D38E7A2D-3DD6-47F0-90D9-C62458824356</gtr:id><gtr:impact>Insight into 3D structure of LYVE-1 protein and the mode of its interaction with hyaluronan core to focus of my group research</gtr:impact><gtr:outcomeId>EbhDhAN4xA7-1</gtr:outcomeId><gtr:partnerContribution>Expertise in Protein Crystallography and associated physical techniques</gtr:partnerContribution><gtr:piContribution>Research using X-Ray crystallography carried out by my Unit postDOC Suneale Banerji with assistance from Robert Gilbert at Wellcome Trust Centre for Human Genomics, Oxford</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Physiology, Anatomy and Genetics</gtr:department><gtr:description>Paul Riley collaboration</gtr:description><gtr:id>616F5A15-6B39-4059-834C-3BE70584239E</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:outcomeId>56d9f0ebd64407.71096103-1</gtr:outcomeId><gtr:partnerContribution>Reagents advice and expertise</gtr:partnerContribution><gtr:piContribution>Reagents advice and expertise</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>Sriskandan collaboration</gtr:description><gtr:id>A5872B71-558A-4C29-B373-5CB6019C6F81</gtr:id><gtr:impact>Publication in PLoS Pathogens 2015 PMID 26352587 

Multidsciplinary

Immunology
Bacteriology
Infectious Diseases</gtr:impact><gtr:outcomeId>azvmk1hfP3y-1</gtr:outcomeId><gtr:partnerContribution>Provision of wild-type and mutant strains of Strep pyogenes and participation of post-doctoral scientist</gtr:partnerContribution><gtr:piContribution>Design of experiments and advise on performing experiments to assess interactions between hyaluronan encapsulated Group A strep and lymphatic endothelial cells leading to possible transport to lymph nodes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centre for Cooperative Research in Biomaterials (CIC BiomaGUNE)</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:department>Biosurfaces Research Unit</gtr:department><gtr:description>Ralf Richter collaboration</gtr:description><gtr:id>C4325407-6C8F-4306-829B-F1D4B7CBF2C5</gtr:id><gtr:impact>27679982 27332136 Multidisciplinary Biochemistry, Biophysics, Immunology</gtr:impact><gtr:outcomeId>AB7VhViwHPy-1</gtr:outcomeId><gtr:partnerContribution>Expertise in physical biochemical techniques</gtr:partnerContribution><gtr:piContribution>Generation of protein reagents for ligand binding analysis by monitoring changes in mass and viscoelastic properties using accoustic resonance measurements (Quartz Crystal Microbalance with dissipation monitoring - QCM-D) technique and Atomic Force Spectroscopy. Intellectual input experimental design and analysis, co-authoring</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit (Oxford)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>34ABFF53-192F-405F-A451-258053EF6194</gtr:id><gtr:impact>Approx 30 primary school pupils participated in an interactive session with Suneal Banerji my senior post-doc who gave them an introductory presentation on immunology and the lymphatic system. This was extremely well received and sparked many questions and discussion both during and afterwards.</gtr:impact><gtr:outcomeId>58c81692694fd3.26717773</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>592795</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant Streptococcal dissemination</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L008610</gtr:fundingRef><gtr:id>0BD30AFC-6EDB-4137-A0CC-44190E495213</gtr:id><gtr:outcomeId>gBR6LHBzt9h</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Hybridomas producing monoclonal antibodies to human LYVE-1 were licensed to Merck Millipore on a non-exclusive basis.The mAbs will be included in their catalogue for non-medical use.</gtr:description><gtr:grantRef>MC_UU_12010/2</gtr:grantRef><gtr:id>4963AC42-1E9A-4FA9-A97A-DA63453F1852</gtr:id><gtr:impact>N.A.</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>58c813988d5045.87788147</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>Licensing of monoclonal antibodies</gtr:title><gtr:yearProtectionGranted>2016</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Academy of Finland</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>97DD16A4-AA25-4088-AB61-1B642CA2383F</gtr:id><gtr:impact>Advised on appointment of prestigious Professorship</gtr:impact><gtr:outcomeId>54622a6a6149e5.80776614</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Fondazione Cariplo grant review</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>BDFE5D14-88FD-40FB-9E7F-0F85D8AFC88E</gtr:id><gtr:impact>Reviewed grant proposals for Italian biomedical science funding body</gtr:impact><gtr:outcomeId>5462282543ff76.20504369</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Finnish Academy of Sciences</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>95D893A2-F97D-41D9-B0B9-B4FC92BDD845</gtr:id><gtr:impact>Sat on Grant review committee</gtr:impact><gtr:outcomeId>56d9faf348a235.77332219</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Review of DK Plus postgraduate research training program</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>A7B62EC8-9BF8-4387-9421-C5EE0B834A5D</gtr:id><gtr:impact>Evaluation and rating of PhD students and PIs associated with Austrian Government funded program</gtr:impact><gtr:outcomeId>546227456ca5b3.38809464</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Lund University</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>A81F470D-671A-4694-97A4-1847FF304A41</gtr:id><gtr:impact>Advised on appointment of prestigious Professorship</gtr:impact><gtr:outcomeId>54622abcf0e850.16610377</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Organisation of University postgraduate research training course</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>A3D2E3A4-3973-4099-9FAE-B7B32A893772</gtr:id><gtr:impact>Optimisation of Institute lecture course for first year DPhil students with aim of broadening knowledge in key areas of biomedical research techniques</gtr:impact><gtr:outcomeId>5462265fcafe62.50537683</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Membership of MRC Infection and Immunity Board</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DFB38BDD-EDB8-409B-87B5-C1A5E6B2DF22</gtr:id><gtr:outcomeId>d7YHZS4oHJw</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Identified molecular markers induced in lymphatic vessels of murine metastatic tumours by comparison with normal tissue lymphatics. Confirmed expression also in human cancers.</gtr:description><gtr:id>468D60CC-9B51-4562-A827-20FB095ACF21</gtr:id><gtr:impact>Used lymphatics markers to predict metastasis in colorectal/head and neck cancers. Identified receptor molecules that are liely to be mechanistically involved in lymphatic metastasis of tumours.</gtr:impact><gtr:outcomeId>44FC968BBDB</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Tumour-induced lymphatic vessel markers</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>First crystal showing molecular details of interaction between a hyaluronan receptor and its ligand hyaluronan. Determined structure in the case of the primary receptor CD44 that is involved in inflammatory leukocyte trafficking and tumour metastasis</gtr:description><gtr:id>68AC0F00-37A9-41AB-B050-6CDA613CA7A2</gtr:id><gtr:impact>Major boost to fundamental biology. Template for design of small molecule inhibitors of CD44 function with possible therapeutic potential</gtr:impact><gtr:outcomeId>BFDB03EA9B3</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Crystal structure of CD44 receptor ligand complex</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Primary lymphatic endothelial cells isolated by immunomagnetic bead selection from human skin, mouse skin and human colorectal tissue</gtr:description><gtr:id>4FA1034F-7CCF-4A24-BDFC-344E2D33EA17</gtr:id><gtr:impact>Ability to analyze molecular details of lymphatic vessel physiology and to establish various assays for cell adhesion / transmigration studies with cells of authentic phenotype</gtr:impact><gtr:outcomeId>34D29A02B97</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Primary lymphatic endothelial cells</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Defined properties of mAbs generated against lymphatic vessel receptor as being function blocking for leukocyte trafficking in lymphatics</gtr:description><gtr:id>3E44F718-A7DE-4238-867D-5A9AA86899B3</gtr:id><gtr:impact>Use of mAbs identifies lymphatic receptor as important for leukocyte movement from tissues to lymph nodes in inflammation</gtr:impact><gtr:outcomeId>33A86AB63EB</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Function blocking antibodies</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Imaging of hyaluronan on surface of dendritic cells in mouse tissues and in mouse and human tissue-derived dendritic cells using biotinylated VG1. Analaysis of dendritic cell trafficking in mouse inflamed skin lymphatics before/after depletion of surface hyaluronan using 4-MU and hyaluronidase.</gtr:description><gtr:id>37FAB8D7-12B9-4577-AF94-5D1312D5BE18</gtr:id><gtr:impact>Publication in upcoming Nature Immunology paper (Johnson LA et al In Press 2017). Related aspects (HA glycocalyx in mouse macrophages) published in PMID 26823460</gtr:impact><gtr:outcomeId>58c6c944c54c68.32467593</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Charcaterisation of leucocyte hyaluronan surface glycocalyx and its role in lymphatic docking and entry</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D73DA69C-0DBD-4562-BDC2-FB6B6AF82DA9</gtr:id><gtr:title>Progression of carcinogen-induced fibrosarcomas is associated with the accumulation of na&amp;iuml;ve CD4+ T cells via blood vessels and lymphatics.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3441c03103165dcfb5bb79efb38b06ef"><gtr:id>3441c03103165dcfb5bb79efb38b06ef</gtr:id><gtr:otherNames>Ondondo B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>54624c020a9618.15586602</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C23CA402-4A8E-4A77-B5EB-532E66549CE3</gtr:id><gtr:title>Lymph vessel density in seminomatous testicular cancer assessed with the specific lymphatic endothelium cell markers D2-40 and LYVE-1: correlation with pathologic parameters and clinical outcome.</gtr:title><gtr:parentPublicationTitle>Urologic oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed8f320eafa3ba62c93e69c550b4b307"><gtr:id>ed8f320eafa3ba62c93e69c550b4b307</gtr:id><gtr:otherNames>Heinzelbecker J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1078-1439</gtr:issn><gtr:outcomeId>5460fcc1e62bf5.79836878</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B925E929-8B55-4563-96B4-7F45FB5E03F8</gtr:id><gtr:title>Rapid Lymphatic Dissemination of Encapsulated Group A Streptococci via Lymphatic Vessel Endothelial Receptor-1 Interaction.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/840026b834f509877f4481f21ae5dadf"><gtr:id>840026b834f509877f4481f21ae5dadf</gtr:id><gtr:otherNames>Lynskey NN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>5675eb44d74c8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08940B52-783F-4AED-B99E-D72F6C9CCF2A</gtr:id><gtr:title>A single molecule assay to probe monovalent and multivalent bonds between hyaluronan and its key leukocyte receptor CD44 under force.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85b473ae2e91f2c4fdf17dd3b7aab9e8"><gtr:id>85b473ae2e91f2c4fdf17dd3b7aab9e8</gtr:id><gtr:otherNames>Bano F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58c6beb8ed3b49.33183841</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3403F6D0-CFC7-411B-A455-7877A3D0F332</gtr:id><gtr:title>Homodimerization of the Lymph Vessel Endothelial Receptor LYVE-1 through a Redox-labile Disulfide Is Critical for Hyaluronan Binding in Lymphatic Endothelium.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/448b5f7fd751cf272bebade77e3e8ec3"><gtr:id>448b5f7fd751cf272bebade77e3e8ec3</gtr:id><gtr:otherNames>Banerji S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>58c6be303ef6c7.61844410</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>524C4385-F5EC-436F-A246-64A9E62D10F5</gtr:id><gtr:title>Lymphatic Regulation of Cellular Trafficking.</gtr:title><gtr:parentPublicationTitle>Journal of clinical &amp; cellular immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46606e6b4b9cbcbe71270c0189081d2a"><gtr:id>46606e6b4b9cbcbe71270c0189081d2a</gtr:id><gtr:otherNames>Jackson DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>54624d6c69aed9.71378638</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFFA6B72-30EC-4E91-9639-7EE9AA8E4BD7</gtr:id><gtr:title>The chemokine CX3CL1 promotes trafficking of dendritic cells through inflamed lymphatics.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4045ec99722c5d534bac690f76cfe482"><gtr:id>4045ec99722c5d534bac690f76cfe482</gtr:id><gtr:otherNames>Johnson LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>pm_16085_25_24006262</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8ED21A56-8B4B-4064-96E7-8B24E00AF7E7</gtr:id><gtr:title>Hyaluronan in the lymphatics: The key role of the hyaluronan receptor LYVE-1 in leucocyte trafficking.</gtr:title><gtr:parentPublicationTitle>Matrix biology : journal of the International Society for Matrix Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46606e6b4b9cbcbe71270c0189081d2a"><gtr:id>46606e6b4b9cbcbe71270c0189081d2a</gtr:id><gtr:otherNames>Jackson DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0945-053X</gtr:issn><gtr:outcomeId>5aa00223052f60.34317423</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B21FB0EC-2D26-4E15-8129-20EE94CFADB8</gtr:id><gtr:title>TGF? counteracts LYVE-1-mediated induction of lymphangiogenesis by small hyaluronan oligosaccharides.</gtr:title><gtr:parentPublicationTitle>Journal of molecular medicine (Berlin, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b058627d77c969d75c6d0d2d1eac96dc"><gtr:id>b058627d77c969d75c6d0d2d1eac96dc</gtr:id><gtr:otherNames>Bauer J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0946-2716</gtr:issn><gtr:outcomeId>5aa003118dfdb5.98745273</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>552B529F-4268-4F12-88C2-534118167873</gtr:id><gtr:title>Critical importance of appropriate fixation conditions for faithful imaging of receptor microclusters.</gtr:title><gtr:parentPublicationTitle>Biology open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1fac10b542eaed272c44ecdc1f1bedb8"><gtr:id>1fac10b542eaed272c44ecdc1f1bedb8</gtr:id><gtr:otherNames>Stanly TA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2046-6390</gtr:issn><gtr:outcomeId>58c6beb93f3276.15013669</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CB13932-4344-49A5-BFD4-36A2A755E903</gtr:id><gtr:title>Micromechanical Analysis of the Hyaluronan-Rich Matrix Surrounding the Oocyte Reveals a Uniquely Soft and Elastic Composition.</gtr:title><gtr:parentPublicationTitle>Biophysical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7771ec39b9bd63d704f50fabca5f24ae"><gtr:id>7771ec39b9bd63d704f50fabca5f24ae</gtr:id><gtr:otherNames>Chen X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn><gtr:outcomeId>58c6beb976bc77.19893336</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29CD160F-0018-49A8-A0D8-33CFD3060510</gtr:id><gtr:title>Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4045ec99722c5d534bac690f76cfe482"><gtr:id>4045ec99722c5d534bac690f76cfe482</gtr:id><gtr:otherNames>Johnson LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>5aa3b33c1fb6c9.61385526</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5870E54-9847-48ED-AE2F-C308C43F84A2</gtr:id><gtr:title>Dendritic Cells enter lymphatic vessels by hyaluronan-mediated docking to the endothelial receptor LYVE1</gtr:title><gtr:parentPublicationTitle>Nature Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a01f8e21ad48842184573e8dc13b45d"><gtr:id>4a01f8e21ad48842184573e8dc13b45d</gtr:id><gtr:otherNames>Johnson, LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58c6c0409a1d70.60617189</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D77A65B1-A1CF-4593-82BF-B98A72108A49</gtr:id><gtr:title>Binding of Hyaluronan to the Native Lymphatic Vessel Endothelial Receptor LYVE-1 Is Critically Dependent on Receptor Clustering and Hyaluronan Organization.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6739e435f0f576bed26e0b7c3ffba3bf"><gtr:id>6739e435f0f576bed26e0b7c3ffba3bf</gtr:id><gtr:otherNames>Lawrance W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>56d9edf11e6ef0.41487626</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0E6B2FA-A7CE-4CD5-8165-C76ECCEBB105</gtr:id><gtr:title>Prostaglandin D2 and leukotriene E4 synergize to stimulate diverse TH2 functions and TH2 cell/neutrophil crosstalk.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/972bcd649809975a6ae6579df5d505cb"><gtr:id>972bcd649809975a6ae6579df5d505cb</gtr:id><gtr:otherNames>Xue L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>54624f6feab6c2.35997770</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6E580FE-2DCB-4909-8602-5C51C3506454</gtr:id><gtr:title>Neutrophils rapidly transit inflamed lymphatic vessel endothelium via integrin-dependent proteolysis and lipoxin-induced junctional retraction.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/945c6964541242efb497ae28217e4fe5"><gtr:id>945c6964541242efb497ae28217e4fe5</gtr:id><gtr:otherNames>Rigby DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn><gtr:outcomeId>56da0175506047.95675988</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8152BD1E-587E-4354-B4E4-DC20A02CAF6D</gtr:id><gtr:title>Control of dendritic cell trafficking in lymphatics by chemokines.</gtr:title><gtr:parentPublicationTitle>Angiogenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4045ec99722c5d534bac690f76cfe482"><gtr:id>4045ec99722c5d534bac690f76cfe482</gtr:id><gtr:otherNames>Johnson LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0969-6970</gtr:issn><gtr:outcomeId>pm_16085_25_24232855</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04658190-0A85-4700-BB30-B6006FCA0F3B</gtr:id><gtr:title>Immunohistochemical Methods for Measuring Tissue Lymphangiogenesis.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c1cd2e054f81d793f6abaa361dd318d"><gtr:id>3c1cd2e054f81d793f6abaa361dd318d</gtr:id><gtr:otherNames>Royston DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>56da04a895b5c8.71486504</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F27619C-355F-41C3-9E68-4896BF7F5710</gtr:id><gtr:title>Syk and Src family kinases regulate C-type lectin receptor 2 (CLEC-2)-mediated clustering of podoplanin and platelet adhesion to lymphatic endothelial cells.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f51a36498ea6d5f47c6091855b62e0d4"><gtr:id>f51a36498ea6d5f47c6091855b62e0d4</gtr:id><gtr:otherNames>Pollitt AY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>54624c4a263ec2.68625268</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UU_12010/2</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>